Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series

Osteonecrosis of the jaw has been recently reported in patients receiving denosumab for the treatment of metastatic bone disease or osteoporosis. It is essential to investigate this disease as a new osteonecrosis entity in order to recognize its optimal management strategies.

https://ift.tt/2so8aap